Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
France
/
Pharmaceuticals & Biotech
Create a narrative
Sanofi Community
ENXTPA:SAN Community
1
Narratives
written by author
0
Comments
on narratives written by author
113
Fair Values set
on narratives written by author
Create a narrative
Sanofi
Popular
Undervalued
Overvalued
Community Investing Ideas
Sanofi
AN
AnalystConsensusTarget
Consensus Narrative from 21 Analysts
ALTUVIIIO And Beyfortus Launches Will Strengthen Future Market Position
Key Takeaways Strong R&D and pipeline advancements position Sanofi for future revenue growth with promising new launches and expanded indications. Strategic initiatives like share buybacks and enhanced production efficiencies suggest potential earnings and margin improvements.
View narrative
€119.28
FV
24.9% undervalued
intrinsic discount
5.73%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
82
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
SAN
SAN
Sanofi
Your Fair Value
€
Current Price
€89.62
4.5% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
57b
2015
2018
2021
2024
2025
2027
2030
Revenue €56.9b
Earnings €7.1b
Advanced
Set Fair Value